The Swedish nationwide experience of converting transplant patients treated with sandimmun to the new galenic formulation sandimmun-neoral
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 280-283
- https://doi.org/10.1016/s0041-1345(96)00093-0
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Clinical Development of a Cyclosporine Microemulsion in TransplantationTherapeutic Drug Monitoring, 1996
- CONSISTENT ABSORPTION OF CYCLOSPORINE FROM A MICROEMULSION FORMULATION ASSESSED IN STABLE RENAL TRANSPLANT RECIPIENTS OVER A ONE-YEAR STUDY PERIODTransplantation, 1995
- Acute effect of cyclosporin on renal function following the initial changeover to a microemulsion formulation in stable kidney transplant patientsTransplant International, 1995
- Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patientsTransplant International, 1994
- CYCLOSPORINE PHARMACOKINETICS AND VARIABILITY FROM A MICROEMULSION FORMULATION—A MULTICENTER INVESTIGATION IN KIDNEY TRANSPLANT PATIENTSTransplantation, 1994
- PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS—A CONCENTRATION-CONTROLLED COMPARISON WITH THE COMMERCIAL FORMULATIONTransplantation, 1994